Close Menu

NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen filed a prospectus on Tuesday for an initial public offering to raise up to about $37 million. 

The Gaithersburg, Md.-based company has not priced its shares yet or said how many shares it plans to offer. It intends to list on the Nasdaq Capital Market under ticker symbol "OPGN." The Maxim Group is listed on OpGen's Form S-1 filed with the US Securities and Exchange Commission as the underwriter for the offering. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.